• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,391.25
    -41.55 (--0.07%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,047.00(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,058.45(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Unjha Formulations Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 7112.0
  • ISIN : INE576D01015
24.30 -1 (-4.82%)
  • As on 30 Apr 2025 (EOD)

  • Today’s Low

    24.00

  • Today’s High

    24.30

  • Open

    24.10

  • Perv Close

    25.53

  • 52W Low

    19.99

  • 52W High

    39.00

Key Indicators

  • P/E(TTM)

    17.11

  • Mar.Cap (₹Cr.)

    10.89

  • Div & Yield %

    0.00

  • Book Value(₹)

    7.41

  • Debt-Equity Ratio

    -4.82

  • AGM Date

    29-Apr-2025

  • EPS

    1.42

  • P/E Ratio

    17.11

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    10.89

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    4.48

  • BV (₹)

    7.40

  • Sales( ₹ in Cr.)

    18.50

  • NP (in Cr.)

    0.28

  • NP Var(%)

    -2.0

  • Div%

    0.0

  • CPS (₹)

    0.80

  • EPS (₹)

    0.60

  • Traded Value (₹ in Lakhs)

    10.89

  • 52 Week High

    39.00

  • 52 Week Low

    19.99

  • Price BSE

    24.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    10.89

  • P/C Ratio

    30.00

  • P/E Ratio

    38.70

  • Price Vs.BV

    0.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 18.50 13.15 14.16 9.96 10.60 11.42
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 18.50 13.15 14.16 9.96 10.60 11.42
Other Income 0.01 0.03 0.19 0.22 0.26 0.10
Stock Adjustments 0.22 -0.08 0.24 0.12 -0.34 -0.15
Total Income 18.73 13.10 14.59 10.30 10.52 11.37
EXPENDITURE :            
Raw Materials 15.78 10.61 11.70 7.67 7.86 8.61
Power and Fuel Cost 0.07 0.06 0.06 0.06 0.07 0.07
Employee Cost 0.59 0.51 0.56 0.48 0.44 0.42
Other Manufacturing Expenses 0.89 0.76 1.12 0.92 0.97 0.83
Selling and Administration Expenses 0.82 0.69 0.56 0.72 0.56 0.72
Miscellaneous Expenses 0.00 0.00 0.07 0.08 0.10 0.32
Employee Benefit Expenses 0.59 0.51 0.56 0.48 0.44 0.42
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 18.15 12.64 14.08 9.93 10.01 10.98
Operating Profit 0.58 0.47 0.51 0.35 0.51 0.40
Interest 0.05 0.06 0.13 0.17 0.12 0.01
Gross Profit 0.53 0.41 0.38 0.18 0.39 0.39
Depreciation 0.08 0.08 0.08 0.08 0.08 0.09
Profit Before Tax 0.45 0.33 0.30 0.10 0.31 0.30
Current Tax 0.17 0.05 0.05 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.01 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 0.28 0.28 0.25 0.10 0.31 0.30
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.28 0.28 0.25 0.10 0.31 0.30
Adjustment below Net Profit 0.00 0.00 -2.76 -2.86 -3.17 -3.47
P & L Balance brought forward -2.22 -2.50 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -1.94 -2.22 -2.50 -2.76 -2.86 -3.17
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.62 0.63 0.56 0.23 0.69 0.67
Earnings Per Share(Adj)-Unit Curr 0.62 0.63 0.56 0.23 0.69 0.67
Book Value 6.10 5.48 4.84 4.28 4.05 3.36
Book Value(Adj)-Unit Curr 6.10 5.48 4.84 4.28 4.05 3.36

Shareholding Pattern

  • Promoter Group

    36.93%

  • Public Share Holding

    63.08%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,654,424 36.93 1,654,424 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,654,424 36.93 1,654,424 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 26,058 0.58 22,758 17
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 18,079 0.40 14,879 21
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 542,497 12.11 542,497 13
Individuals holding nominal share capital up to Rs. 1 lakh 2,002,339 44.69 1,492,439 4,163
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 237,103 5.29 237,103 55
Sub Total 2,826,076 63.08 2,309,676 4,269
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 4,480,500 100.00 3,964,100 4,273

Company Background

Unjha Formulations LtdPharmaceuticals - Indian - Formulations

  • Unjha Formulations Ltd
  • BSE Code : 7112.0
  • ISIN : INE576D01015

  • Incorporation Year

    1994

  • Registered Office

    Khali Char Rasta
    State Highway Ta Sidhpur, Patan,
    Gujarat-384151

  • Telephone

    91-2767-282395

  • FAX

    91-2767-282396

  • Chairman

    Jashodaben S Patel

  • Managing Director

    Krutiben M Patel

  • Company Secretary

    Jigar Ray

  • Auditor

    Jain & Golechha/Milind Shah & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Link Intime India Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road ,Navrangpura
    Mumbai - Ahmedabad-380009

Unjha Formulations Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Unjha Formul. 24.30 18.51 18.50 17.11 10.71
Abbott India 30,094.35 6,097.18 5,848.91 47.92 44.71
Astrazeneca Phar 8,795.90 1,330.33 1,295.53 226.76 33.26
P & G Health Ltd 5,121.00 1,166.89 1,151.26 35.93 39.76
Glaxosmi. Pharma 2,904.45 3,530.73 3,407.25 57.75 44.44
Cipla 1,541.00 17,645.00 16,574.34 26.42 20.10
Amrutanjan Healt 679.10 437.58 421.23 39.81 20.84
Guj. Themis Bio. 285.15 174.19 169.82 59.04 44.82
Fermenta Biotec. 272.25 315.24 307.09 25.81 4.10
Bliss GVS Pharma 122.65 638.96 605.46 28.07 11.19
Ambalal Sarabhai 37.10 11.70 3.81 15.85 1.92